Secretory component mRNA and protein expression in colorectal adenomas and carcinomas

British Journal of Cancer

Volumn 73, Issue 12, 1996, Pages 1503-1510

  Krajci P ^a   Meling, G I ^a   Andersen, S N ^a   Hofstad, B ^b   Vatn, M H ^a   Rognum, T O ^a   Brandtzaeg, P ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Colorectal tumour; Expression; Poly Ig receptor; Secretory component

Indexed keywords

MEMBRANE PROTEIN; MESSENGER RNA; SECRETORY COMPONENT;

ADENOMA; ADULT; AGED; ARTICLE; CANCER RISK; COLON CARCINOGENESIS; COLORECTAL CANCER; COLORECTAL CARCINOMA; COLORECTAL TUMOR; EPITHELIUM CELL; GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOUTHERN BLOTTING;

EID: 0030058429     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.284     Document Type: Article

References (58)

1. BRANDTZAEG P. (1974). Mucosal and glandular distribution of immunoglobulin components. Immunohistochemistry with a cold ethanol-fixation technique. Immunology, 26, 1101-1114.
2. BRANDTZAEG P. (1981). Prolonged incubation time in immunohistochemistry: effects on fluorescence staining of immunoglobulins and epithelial components in ethanol- and formaldehyde-fixed paraffin-embedded tissues. J. Histochem. Cytochem., 29, 1302-1315.
3. BRANDTZAEG P. (1985). Role of J chain and secretory component in receptomediated glandular and hepatic transport of immunoglobulins in man. Scand. J. Immunol., 22, 111-146.
4. BRANDTZAEG P AND PRYDZ H. (1984). Direct evidence for an integrated function of J chain and secretory component in epithelial transport of immunoglobulin. Nature, 311, 71-73.
5. BRANDTZAEG P, NILSSEN DE, ROGNUM TO AND THRANE PS. (1991). Ontogeny of the mucosal immune system and IgA deficiency. Gastroenterol. Clin. N. Am., 20, 397-439.
6. BRANDTZAEG P, KRAJCI P, LAMM M AND KAETZEL CS. (1994). Epithelial and hepatobiliary transport of IgA. In Mucosal Immunology, Vol. I: Cellular Basis of Mucosal Immunity. Ogra PL, Mestecky J, Lamm M, Strober W, McGhee J and Bienenstock J. (eds) pp.113-126. Academic Press: Orlando, FL.
7. BREITFELD PB, CASANOVA JE, MCKINNON WC AND MOSTOV KE. (1990). Deletions in the cytoplasmic domain of the polymeric immunoglobulin receptor differentially affect endocytotic rate and postendocylotic traffic. J. Biol. Chem., 265, 13750-13757.
8. BRITO-BABAPULLE V AND ATKIN NB (1981). Break points in chromosome #1: abnormalities of 218 human neoplasms. Cancer Genet. Cytogenet., 4, 215-225.
9. THE CANCER REGISTRY OF NORWAY. (1982). Trends in Cancer Incidence in Norway. 1955-78. The Cancer Registry of Norway: Oslo.
10. CASANOVA JE, BREITFELD PP, ROSS SA AND MOSTOV KE. (1990). Phosphorylation of the polymeric immunoglobulin receptor required for its efficient transcytosis. Science, 248, 742-745.
11. CLEVELAND DW, LOPATA MA, MACDONALD J, COWAN NJ, RUTTER WJ AND KIRSCHNER MW. (1980). Number of evolutionary conservation of alpha- and beta-tubulin and cytoplasmic beta- and gamma-actin genes using specific cloned cDNA probes. Cell, 20, 95-105.
12. CONLEY ME AND DELACROIX DL. (1987). Intravascular and mucosal immunglobulin A: Two separate but related systems of immune defense? Ann. Int. Med., 106, 892-899.
13. CORREA P AND HAENSZEL W. (1978). The epidemiology of large-bowel cancer. Adv. Cancer Res., 26, 1-141.
14. DAVIDSON MK, LE BEAU MM, EDDY RL, SHOWS TB, DIPIETRO LA, KINGZETTE M AND HANLY WC. (1988). Genetic mapping of the human polymeric immunoglobulin receptor gene to chromo-some region Lq31-q41. Cytogenet. Cell. Genet., 48, 107-111.
15. DORAN J AND HARDCASTLE JD. (1982). Bleeding patterns in colorectal cancer: the effect of aspirin and the implications for faecal occult blood testing. Br. J. Surg., 69, 711-713.
16. DUKES CE AND BUSSEY HR. (1958). The spread of rectal cancer and its effects on prognosis. Br. J. Cancer, 12, 309-320.
17. FALCONE D AND ANDREWS DW. (1991). Both the 5′ untranslated region and the sequences surrounding the start site contribute to efficient initiation of translation in vitro. Mol. Cell Biol., 11, 2656-2664.
18. FEINBERG AP AND VOGELSTEIN B. (1984). A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Addendum Anal. Biochem., 137, 266-267.
19. GIACOSA A, SUKKAR SG AND FRASCIO. (1987). The surveillance of high risk patients for colorectal cancer. In Causation and Prevention of Colorectal Cancer. Faivre J and Hill M (eds). Elsevier Science Publishers: Amsterdam.
20. HOFF G, MOEN IE, TRYGG K, FROLICH W, SAUAR J, VATN M, GJONE E AND LARSEN S. (1986). Epidemiology of polyps in the rectum and sigmoid colon. Evaulation of nutritional factors. Scand. J. Gastroenterol., 21, 199-204.
21. HOFSTAD B, VATN M, LARSEN S AND OSNES M. (1992). Reliability of in situ measurements of colorectal polyps. Scand. J. Gastroenterol., 27, 59-64.
22. ISAACSON P. (1982). Immunoperoxidase study of the secretory immunoglobulin system in colonic neoplasia. J. Clin. Pathol., 34, 14-25.
23. JASS JR AND SOBIN LH. (1989). Histological Typing of Intestinal Tumours, 2nd edn. World Health Organization, Springer: Geneva.
24. KORETZ K, SCHLAG P, QUENTMEIER A AND MÖLLER P. (1994). Evaluation of the secretory component as a prognostic variable in colorectal carcinoma. Int. J. Cancer, 57, 365-370.
25. KRAJ̌CI P, SOLBERG R, SANDBERG M, ØYEN O, JAHNSEN T AND BRANDTZAEG P. (1989). Molecular cloning of the human transmembrane secretory component (poly-Ig receptor) and its mRNA expression in human tissues. Biochem. Biophys. Res. Commun., 158, 783-789.
26. KRAJ̌CI P, GRZESCHIK K-H, GEURTZ VAN KESSEL, OLAISEN B AND BRANDTZAEG P. (1991). The human transmembrane secretory component (poly-Ig receptor): molecular cloning, restriction fragment length polymorphism and chromosomal sublocalization. Hum. Genet., 87, 642-648.
27. KRAJ̌CI P, GEDDE-DAHL T JR, HØYHEIM B, ROGDE S, OLAISON B AND BRANDTZAEG P. (1992). The gene encoding human transmembrane secretory component (locus PIGR) is linked to D1S58 on chromosome 1. Hum. Genet., 90, 215-219.
28. KRAJ̌CI P, TASKÉN K, KVALE D AND BRANDTZAEG P. (1993). Interferon-γ stimulation of messenger RNA for human secretory component (poly-Ig receptor) depends on continuous intermediate protein synthesis. Scand. J. Immunol, 37, 251-256.
29. KRAKAUER R, ZINNEMAN HH AND HONG R. (1975). Deficiency of secretory Ig-A and intestinal malabsorption. Am. J. Gastroenterol., 64, 319-323.
30. KVALE D, BRANDTZAEG P AND LØVHAUG D. (1988). Up-regulation of the expression of secretory component and HLA molecules in a human colonic cell line by tumour necrosis factor-alfa and gamma interferon. Scand. J. Immunol., 28, 351-357.
31. MACEJAK DG AND SARNOW P. (1990). Translational regulation of the immunoglobulin heavy-chain binding protein mRNA. Enzyme, 44, 310-319.
32. MATEK W, GUGGENMOOS-HOLZMANN I AND DEMLING L. (1985). Follow-up of patients with colorectal adenomas. Endoscopy, 17, 175-181.
33. MELING GI, LOTHE RA, BØRRESEN AL, GRAUE C, HAUGE S, CLAUSEN OP AND ROGNUM TO. (1993). The TP53 tumour suppressor gene in colorectal carcinomas. I. Genetic alterations on chromosome 17. Br. J. Cancer, 67, 88-92.
34. MORSON BC. (1974). The polyp-cancer sequence in the large bowel. Proc. R. Soc. Med., 67, 451-457.
35. MORSON BC AND SOBIN LH. (1976). International Histological Classification of Tumours, no 15. World Health Organization: Geneva.
36. MOSTOV KE. (1994). Transepithelial transport of immunoglobulins. Annu. Rev. Immunol., 12, 63-84.
37. MOSTOV KE AND BLOBEL G. (1982). A transmembrane precursor of secretory component. The receptor for transepithelial transport of secretory immunoglobulins. J. Biol. Chem., 251, 11816-11821.
38. MUNROE D AND JACOBSON A. (1990). mRNA poly(A) tail, a 3′ enhancer of translational initiation. Mol. Cell. Biol., 10, 3441-3455.
39. NAKAMURA Y, CULVER M, O'CONNELL P, LEPPERT M, LATHROP GM, LALOUEL J-M AND WHITE R. (1987). Isolation and mapping of a polymorphic DNA sequence pYNZ23 to chromosome 1 (D1S58). Nucleic Acids Res., 15, 9620.
40. NUSSINSON E, LAHAV M, BEREBI A, ESTROV Z, ZUR S AND RESNITZKY P. (1986). Secretory piece and IgA deficiency in a patient with Waldenstrom's macroglobulinemia. Am. J. Gastroenterol., 81, 995-998.
41. PERLMUTTER RM. (1990). Translational regulation of the lymphocyte-specific protein tyrosine kinase p56lck. Enzyme, 44, 214-224.
42. PHILLIPS JO, EVERSON MP, MOLDOVEANU Z, LUE C AND MESTECKY J. (1990). Synergistic effects of IL-4 and IFN-γ on the expression of polymeric Ig-receptor (secretory component) and IgA binding to human epithelial cells. J. Immunol., 145, 1740-1744.
43. PISKURICH JF, FRANCE JA, TAMER CM, WILLMER CA, KAETZEL CS AND KAETZEL DM. (1993). Interferon-γ induces polymeric immunoglobulin receptor mRNA in human intestinal epithelial cells by a protein synthesis dependent mechanism. Mol. Immunol., 30, 413-421.
44. PLAUT AG AND RIDKER P. (1992). New light on secretory-component deficiency [letter]. N. Eng. J. Med., 327, 129.
45. ROGNUM TO, BRANDTZAEG P, ÖRJASAETER H, ELGJO K AND HOGNESTAD J. (1980). Immunohistochemical study of secretory component, secretory IgA and carcino-embryonic antigen in large bowel carcinomas. Path. Res. Pract., 170, 126-145.
46. ROGNUM TO, ELGJO K, FAUSA O AND BRANDTZAEG P. (1982a). Immunohistochemical evaluation of carcinoembryonic antigen, secretory component, and epithelial IgA in ulcerative colitis with dysplasia. Gut, 23, 123-133.
47. ROGNUM TO, FAUSA O AND BRANDTZAEG P. (1982b). Immunohistochemical evaluation of carcino-embryonic antigen, secretory component and epithelial IgA in tubular and villous large-bowel adenomas with different grades of dysplasia. Scand. J. Gastroenterol., 7, 341-338.
48. RYAZANOV AG, RUDKIN BB AND SPIRIN AS. (1991). Regulation of protein synthesis at the elongation stage. New insights into the control of gene expression in eukaryotes. FEBS Lett., 285, 170-175.
49. SCOTT H, BRANDTZAEG P, SOLHEIM BG AND THORSBY F. (1981). Relation between HLA-DR-like antigens and secretory component (SC) in jejunal epithelium of patients with coeliac disease or dermatitis herpetiformis. Clin. Exp. Immunol., 44, 233-238.
50. SIEGEL S. (1956). Non-parametric Statisticas for the Behavioral Sciences. McGraw-Hill Kogakusha: Tokyo.
51. SOLLID LM, GAUDERNACK G, MARKUSSEN G, et al. (1987). Induction of various HLA class II molecules in a human colonic adenocarcinoma cell line. Scand. J. Immunol., 25, 175-180.
52. STAVE R, BRANDTZAEG P. (1977). Fluorescence staining pattern of gastric mucosa. A study with special reference to parietal cells. Scand. J. Gastroenterol., 12, 885-891.
53. STEVENS SS. (1946). On the theory of scales of measurement. Science, 103, 677-680.
54. STROBER W, KRAKAUER R, KLAEVEMAN HL, REYNOLDS HY AND NELSON DY. (1976). Secretory component deficiency. A disorder of the IgA immune system. N. Engl. J. Med., 294, 351-356.
55. THRANE PS, SOLLID LM, HAANES HR AND BRANDTZAEG P. (1992). Clustering of IgA-producing immunocytes related to HLA-DR-positive ducts in normal and inflamed salivary glands. Scand. J. Immunol., 35, 43-51.
56. VALNES K, BRANDTZAEG P, ELGJO K AND STAVE R. (1984). Specific and nonspecific humoral defense factors in the epithelium of normal and inflamed gastric mucosa. Immunohistochemical localization of immunoglobulins, secretory component, lysozyme, and lactoferrin. Gastroenterology, 86, 402-412.
57. VOGELSTEIN B, FEARON ER, KERN SE, HAMILTON SR, PREISINGER AC, NAKAMURA Y AND WHITE R. (1989). Allelotype of colorectal carcinomas. Science, 244, 207-211.
58. YOON H AND DONAHUE TF. (1992). Control of translation initiation in Saccharomyces cerevisiae. Mol. Microbiol., 6, 1413-1419.